Fox Run Management »

Fulcrum Therapeutics shares owned by Fox Run Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Fox Run Management from 13F filings

Historical chart of Fox Run Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Fox Run Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Fox Run Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $467k 51k 9.20

More positions owned by Fox Run Management

Select Sector Spdr Tr Energy (XLE)
Select Sector Spdr Tr Financial (XLF)
Ishares Tr U.s. Real Es Etf (IYR)
Microchip Technology (MCHP)
Sba Communications Corp Cl A (SBAC)
Paylocity Holding Corporation (PCTY)
Sprouts Fmrs Mkt (SFM)
HEICO Corporation (HEI)
Regeneron Pharmaceuticals (REGN)
Brinker International (EAT)
Insulet Corporation (PODD)
Hubspot (HUBS)
Zebra Technologies Corporati Cl A (ZBRA)
Stryker Corporation (SYK)
Atlassian Corporation Cl A (TEAM)

View all positions for Fox Run Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Adage Capital Partners GP
Balyasny Asset Management
D. E. Shaw & Co
Dimensional Fund Advisors
Ikarian Capital
State Street Corporation
Geode Capital Management
Royal Bank of Canada
Citadel Advisors

View all funds holding Fulcrum Therapeutics